Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 6/20 | 0.60 |
| ▸ | CTSB | P07858 | 5/20 | 0.60 |
| ▸ | REN | P00797 | 2/20 | 0.59 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | ECE1 | P42892 | 3/20 | 0.57 |
| ▸ | MME | P08473 | 2/20 | 0.57 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.56 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | CASP7 | P55210 | 1/20 | 0.55 |
| ▸ | CTSD | P07339 | 1/20 | 0.55 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | CTSS | P25774 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25287172 | 0.93 | ECE1 (0.61) | CTSKCTSBECE1MMECAPN1 | |
| SCHEMBL3058668 | 0.93 | ECE1 (0.61) | CTSKCTSBECE1MMECAPN1 | |
| SCHEMBL9830575 | 0.93 | CAPN1 (0.62) | CTSKCTSBRENECE1MME | |
| SCHEMBL1436898 | 0.93 | CAPN1 (0.62) | CTSKCTSBRENECE1MME | |
| SCHEMBL6271137 | 0.90 | CASP3 (0.64) | CTSKCTSBRENCASP1ECE1 | |
| SCHEMBL4402534 | 0.90 | CAPN1 (0.59) | CTSKCTSBRENECE1MME | |
| SCHEMBL4402523 | 0.90 | CAPN1 (0.59) | CTSKCTSBRENECE1MME | |
| Carbon Dioxide SCHEMBL2254435 | 0.90 | CTSK (0.60) | CTSKCTSBRENECE1MME | |
| SCHEMBL8585984 | 0.89 | ECE1 (0.57) | CTSKCTSBECE1MMECAPN1 | |
| SCHEMBL8612642 | 0.89 | ECE1 (0.64) | CTSKCTSBRENCASP1ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120091810-A | Methods and highly bioavailable permeable compounds for treating viral diseases | 基里尔·迪丹克 | 2025-06-03 | — | — | CN | disclosed |